Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely used for heart failure, work by activating a key enzyme that helps heart cells produce and use energy more efficiently. The study, published today in Science, potentially solves a longstanding gap in knowledge about these drugs and opens the door to potential new treatments…
A new report shows the increasing rate of women and girls being treated for endometriosis in hospitals may signal better awareness of the chronic condition.
The widow of a man who died with a rare neurodegenerative disease says the Northern Territory's new voluntary assisted dying laws are "very weak" and will fail many who need them.
The FDA approved Roivant’s dermatomyositis drug brepocitinib on Wednesday, the first major regulatory nod that could usher in a multibillion revenue stream for the hub-and-spoke pharma.
